For folks who simply cannot acquire ibuprofen or acetaminophen, Eastman Institute for Oral Health researchers investigated the use of a gabapentin blend as a non-opioid replacement.
A latest College of Rochester research demonstrates a doable substitute for opioids for post-dental extraction agony.
Investigation from the College of Rochester Health care Center’s Eastman Institute for Oral Overall health (EIOH) features hope for a non-opioid answer for acute dental agony as the opioid crisis carries on all over the
The research, which was published in JAMA Network Open, examines two sizable patient groups that include an equal number of men and women between the ages of 18 and 93 who had tooth extractions at the Institute’s Howitt Urgent Dental Care clinic in Rochester, New York.
“We hypothesized that using a combination of the non-opioid pain medications and adding gabapentin to the mix for pain would be an effective strategy to minimize or eliminate opioids for dental pain,” said Yanfang Ren, DDS, Ph.D., MPH, professor and clinical chief, Howitt Urgent Dental Care.
Ibuprofen or acetaminophen was used to manage mild pain in the 3,300 individuals in the first group in 2012. Patients were given larger dosages of ibuprofen or opioid combinations, such as hydrocodone, oxycodone, or codeine, for moderate to severe pain.
However, the second group of about 3,800 patients who had extractions between March 2021 and February 2022 received no opioids at all.
The second group received the same acetaminophen or ibuprofen prescriptions for mild pain. Higher ibuprofen dosages or an ibuprofen and acetaminophen combination were given for moderate to severe pain.
In 2012, individuals who were unable to take ibuprofen or acetaminophen owing to health difficulties or potential complications with current prescriptions were often prescribed an opioid combination; however, in 2022, a gabapentin combination was used as a non-opioid alternative. When the efficacy was examined using a real-world measure of the percentage of patients returning for further pain treatment after receiving the prescribed analgesics, the findings were promising.
“Although the American Dental Association recommends nonsteroidal anti-inflammatory drugs for managing pain,” Dr. Ren said, “dentists frequently prescribe opioids for dental pain and contribute substantially to new and persistent opioid use. This may partly be explained by the lack of alternatives to opioids, especially when the ibuprofen or acetaminophen are ineffective or can’t be tolerated.”
“This study represents continued efforts by our team and other dentists to minimize the use of opioids for dental pain,” said Eli Eliav, DDS, Ph.D. He is the director of EIOH and a pain expert. “Additional studies, preferably randomized controlled clinical trials, are needed to confirm the safety and effectiveness of this approach. It is our duty to continuously seek safe and effective treatment for our patients in pain.”
Reference: “Comparison of Analgesic Prescriptions for Dental Pain and Patient Pain Outcomes Before vs After an Opioid Reduction Initiative” by Qirong Huang, DDS, MS, Linda Rasubala, DDS, Ph.D., MS, Richard H. Gracely, Ph.D., Junad Khan, BDS, MSD, MPH, Ph.D., Eli Eliav, DMD, Ph.D. and Yanfang Ren, DDS, Ph.D., MPH, 17 August 2022, JAMA Network Open.
DOI: 10.1001/jamanetworkopen.2022.27219
